MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer

Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications

(2017) Maryam Zare et al.   JOURNAL OF CELLULAR PHYSIOLOGY

miR-503-3p promotes epithelial–mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin

(2017) Zitong Zhao et al.   Journal of Genetics and Genomics

Upholding a role for EMT in pancreatic cancer metastasis

(2017) Nicole M. Aiello et al.   NATURE

MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin

(2016) Jun Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer

(2016) Teng Ma et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer

(2016) Zhenhai Ma et al.   IUBMB LIFE

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

(2016) Marco Sciacovelli et al.   NATURE

Role of EMT in Metastasis and Therapy Resistance

(2016) Bethany Smith et al.   Journal of Clinical Medicine

Epithelial-Mesenchymal Transition and Breast Cancer

(2016) Yanyuan Wu et al.   Journal of Clinical Medicine

The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro

(2015) Olga Piskareva et al.   CANCER LETTERS

ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance

(2015) Peijing Zhang et al.   CELL CYCLE

The relevance of EMT in breast cancer metastasis: Correlation or causality?

(2015) Ruben Bill et al.   FEBS LETTERS

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer

(2015) Xiaofeng Zheng et al.   NATURE

Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis

(2014) Weiying Zhou et al.   CANCER CELL

Decreased Expression of miR216a Contributes to Non-Small-Cell Lung Cancer Progression

(2014) R.-T. Wang et al.   CLINICAL CANCER RESEARCH

Breast cancer statistics, 2013

(2013) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer

(2013) S S Roy et al.   ONCOGENE

Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer

(2012) Qin Xu et al.   CARCINOGENESIS

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

(2011) Manav Korpal et al.   NATURE MEDICINE

Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer

(2010) K Vuoriluoto et al.   ONCOGENE

MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer

(2009) Guohong Hu et al.   CANCER CELL

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

(2009) Tetsuya Ueda et al.   LANCET ONCOLOGY

MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells

(2009) D. Iliopoulos et al.   Science Signaling

Poly(ester amine)-mediated, Aerosol-delivered Akt1 Small Interfering RNA Suppresses Lung Tumorigenesis

(2008) Cheng-Xiong Xu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

(2008) Ulrike Burk et al.   EMBO REPORTS

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY